
Journal of Medicinal Chemistry p. 4839 - 4847 (1995)
Update date:2022-08-03
Topics:
Kelly
Proudfoot
McNeil
Patel
David
Hargrave
Grob
Cardozo
Agarwal
Adams
Molecular modeling analysis of the recently published X-ray crystal structure of nevirapine bound to wild type human immunodeficiency virus type I reverse transcriptase (WT-RT) indicated the presence of a lipophilic cavity proximal to the 4-position of the inhibitor. A series of 4-substituted derivatives of nevirapine were thus synthesized to assess structure-activity relationships (SARs) and to see if increased binding to this region might translate into greater activity against mutant RTs. The results show that compounds with an appropriately spaced aryl ring appended to the 4-position of the dipyridodiazepinone ring system show good activity against WT-RT. Furthermore certain derivatives appear to inhibit the Y181C mutant RT. Attempts to combine these results with the recent discovery that 2- substituents enhance activity against the Y181C mutant led to a few compounds with moderate activity against both enzymes. The SAR of these two positions, however, could not be combined in a simple fashion.
View Morewebsite:http://www.shochem.com
Contact:021-50800795
Address:No.1043, Halei Rd, Zhangjiang Hi-Tech Park, Shanghai, Postcode 201203, China
Shanghai Sunwise Chemical Co., Ltd
website:http://www.sunwisechem.com
Contact:86-021-33883180
Address:Room 10E, Building G, Westlink Center, No. 2337 Gudai Road, Minhang District, Shanghai, China PC: 201100
Hangzhou Gangjin Chemical Co.,Ltd.(expird)
Contact:+86-571-85109780
Address:707 Zhejiang Minhang Bldg., No.290 Zhongshan North Road, Hangzhou 310003, China
Zibo Ocean International Trade Co.,Ltd(expird)
Contact:+86 533 5160706
Address:1117, Hongtai Bld., Songling rd, Zichuan,Zibo,Shandong,China
Pure Chemistry Scientific Inc.
Contact:+1-857-366-7588
Address:14905 SW freeway street #232, Sugarland, TX 77478, USA
Doi:10.1039/j39670001639
(1967)Doi:10.1016/0040-4020(95)00747-V
(1995)Doi:10.1016/j.tet.2016.08.085
(2016)Doi:10.1016/0040-4039(95)01909-2
(1995)Doi:10.1002/cctc.201701975
(2018)Doi:10.1016/S0040-4020(97)00071-9
(1997)